PM
CBAY

Prosight Management’s Cymabay Therapeutics CBAY Stock Holding History

Prosight Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-93,923
Closed -$292K – 35
2022
Q1 		$292K Sell
93,923
-72,852
-44% -$226K 0.19% 30
2021
Q4 		$564K Buy
+166,775
New +$564K 0.34% 28